Geode Capital Management, LLC Fortress Biotech, Inc. Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.28 - $0.65 $11,484 - $26,659	41,015 Added 4.77%	900,400 $261,000
Q2 2023 Aug 11, 2023	BUY	$0.49 - $0.82 $78,938 - $132,100	161,098 Added 23.07%	859,385 $472,000
Q1 2023 May 15, 2023	BUY	$0.65 - $1.1 $13,042 - $22,071	20,065 Added 2.96%	698,287 $572,000
Q4 2022 Feb 13, 2023	SELL	$0.48 - $0.88 $732 - $1,342	-1,526 Reduced 0.22%	678,222 $444,000
Q3 2022 Nov 14, 2022	BUY	$0.79 - $22.0 $1,761 - $49,060	2,230 Added 0.33%	679,748 $584,000

Q2 2022 Aug 12, 2022	SELL	$0.8 - $1.5 $475,680 - $891,901	-594,601 Reduced 46.74%	677,518 $569,000
Q1 2022 May 13, 2022	SELL	$1.24 - $2.75 $93,598 - $207,578	-75,483 Reduced 5.6%	1,272,119 $1.73 Million
Q4 2021 Feb 11, 2022	SELL	$2.42 - $3.65 $32,832 - $49,519	-13,567 Reduced 1.0%	1,347,602 $3.37 Million
Q3 2021 Nov 12, 2021	BUY	$2.82 - $3.7 $133,617 - $175,313	47,382 Added 3.61%	1,361,169 $4.38 Million
Q2 2021 Aug 13, 2021	BUY	$3.5 - $5.48 $501,648 - $785,437	143,328 Added 12.25%	1,313,787 $4.69 Million
Q1 2021 May 12, 2021	BUY	$3.16 - $4.89 $751,280 - $1.16 Million	237,747 Added 25.49%	1,170,459 $4.13 Million
Q4 2020 Feb 12, 2021	BUY	$2.2 - $4.45 $100,773 - $203,836	45,806 Added 5.16%	932,712 $2.96 Million
Q3 2020 Nov 13, 2020	BUY	$2.62 - $4.78 $348,276 - $635,405	132,930 Added 17.63%	886,906 $3.58 Million
Q2 2020 Aug 13, 2020	BUY	$1.83 - $3.16 $746,297 - $1.29 Million	407,813 Added 117.81%	753,976 $2.02 Million
Q1 2020 May 14, 2020	SELL	$1.14 - $2.96 $3,801 - $9,871	-3,335 Reduced 0.95%	346,163 $654,000
Q4 2019 Feb 13, 2020	SELL	$1.25 - $2.57 $3,706 - $7,620	-2,965 Reduced 0.84%	349,498 $898,000
Q3 2019 Nov 12, 2019	SELL	$1.26 - $1.96 $4,633 - $7,206	-3,677 Reduced 1.03%	352,463 $496,000
Q2 2019 Aug 14, 2019	SELL	$1.43 - $1.94 $202,337 - $274,500	-141,495 Reduced 28.43%	356,140 $534,000
Q1 2019 May 14, 2019	BUY	$0.94 - $2.47 $110,603 - $290,627	117,663 Added 30.97%	497,635 $885,000
Q4 2018 Feb 13, 2019	BUY	$0.57 - $1.53 $24,646 - $66,155	43,239 Added 12.84%	379,972 $326,000
Q3 2018 Nov 13, 2018	BUY	$1.44 - $3.13 $19,360 - $42,082	13,445 Added 4.16%	336,733 $538,000
Q2 2018 Aug 14, 2018	BUY	$2.92 - $5.1 $61,544 - $107,492	21,077 Added 6.97%	323,288 $963,000
Q1 2018 May 15, 2018	BUY	$3.42 - $5.35 $15,383 - $24,064	4,498 Added 1.51%	302,211 $1.38 Million
Q4 2017 Feb 13, 2018	BUY	$3.26 - $4.84 $9,943 - $14,762	3,050 Added 1.04%	297,713 $1.19 Million
Q3 2017 Nov 14, 2017	BUY	$3.83 - $4.89 $2,677 - $3,418	699 Added 0.24%	294,663 $1.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	293,964	293,964 $1.4 Million

Others Institutions Holding FBIO

# of Institutions

Shares Held

1.01M

Call Options Held

Put Options Held

View Full List

About Fortress Biotech, Inc.

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $194M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

More about FBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account